Allogene Therapeutics, Inc.ALLONASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 17.39% |
| Q2 2025 | 17.86% |
| Q1 2025 | 0.00% |
| Q4 2024 | 12.50% |
| Q3 2024 | 8.57% |
| Q2 2024 | 7.89% |
| Q1 2024 | 25.49% |
| Q4 2023 | -37.84% |
| Q3 2023 | 31.48% |
| Q2 2023 | 20.59% |
| Q1 2023 | -3.03% |
| Q4 2022 | -13.79% |
| Q3 2022 | -11.54% |
| Q2 2022 | 7.14% |
| Q1 2022 | -3.70% |
| Q4 2021 | 5.26% |
| Q3 2021 | -7.55% |
| Q2 2021 | -112.00% |
| Q1 2021 | 52.83% |
| Q4 2020 | -1.92% |
| Q3 2020 | 1.89% |
| Q2 2020 | -6.00% |
| Q1 2020 | 13.79% |
| Q4 2019 | -16.00% |
| Q3 2019 | -21.95% |
| Q2 2019 | -28.12% |
| Q1 2019 | 13.51% |
| Q4 2018 | 2.63% |
| Q3 2018 | 68.07% |
| Q2 2018 | -1916.95% |
| Q1 2018 | -129733.26% |
| Q4 2017 | 0.00% |